🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yvonne A. Efebera

ORCID: 0000-0002-4163-8823

Also affiliated with NHS Blood and Transplant, Ohio Department of Health, KidsOhio, The Ohio State University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 13 papers. Top paper: “A phase I/II study of ixazomib, pomalidomide, and dexamethasone for lenalidomide and proteasome inhibitor refractory multiple myeloma (Alliance A061202)”.

A phase I/II study of ixazomib, pomalidomide, and dexamethasone for lenalidomide and proteasome inhibitor refractory multiple myeloma (Alliance A061202)

American Journal of Hematology(2021)10.1002/ajh.26361

N/A

0.994DataRank · unranked

23 citations

Vera J. Suman, Sascha A. Tuchman, Jacob P. Laubach, Hani Hassoun, Yvonne A. Efebera +7 more

Alliance A061202: ixazomib, pomalidomide, and dexamethasone for patients with lenalidomide-refractory MM in first relapse

Blood Advances(2024)10.1182/bloodadvances.2024013623

N/A

0.372DataRank · unranked

5 citations

Vera J. Suman, Yvonne A. Efebera, Noopur Raje, Sascha A. Tuchman, Cesar Rodriguez Valdes +7 more

RGI-2001 for the prophylaxis of acute graft-versus-host disease after allogeneic HCT

Blood(2025)10.1182/blood.2025029584

N/A

0.292DataRank · unranked

6 citations

Hannah Choe, Yvonne A. Efebera, Ayman Saad, Shatha Farhan, Lazaros J. Lekakis +10 more

Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era

Leukemia(2021)10.1038/s41375-021-01233-1

N/A

0DataRank · unranked

1 citations

Sagar S. Patel, Saulius Girnius, Lohith Bachegowda, Raphael Fraser, Omar Dávila +42 more

Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma

American Journal of Hematology(2022)10.1002/ajh.26596

N/A

0DataRank · unranked

30 citations

Ruta Brazauskas, Edward A. Stadtmauer, Marcelo C. Pasquini, Parameswaran Hari, Asad Bashey +16 more

Long-term follow-up of BMT CTN 0702 (STaMINA) of postautologous hematopoietic cell transplantation (autoHCT) strategies in the upfront treatment of multiple myeloma (MM).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8506

N/A

0DataRank · unranked

102 citations

Marcelo C. Pasquini, Edward A. Stadtmauer, Raphael Fraser, Mingwei Fei, Steven M. Devine +14 more

A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.07.007

N/A

0DataRank · unranked

9 citations

T Nishihori, Marcelo C. Pasquini, Michael J. Martens, Juan Wu, Melissa Alsina +15 more

Beta-Adrenergic Antagonist Tolerance in Amyloid Cardiomyopathy

Frontiers in Cardiovascular Medicine(2022)10.3389/fcvm.2022.907597

N/A

0DataRank · unranked

7 citations

Carlos Bermúdez, Cyril Ayuk Mbeng Takem Baiyee, Brandon Rodgers, Samir M. Parikh, Salem Almaani +10 more

Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial

Research Square(2023)10.21203/rs.3.rs-3318127/v1

N/A

0DataRank · unranked

1 citations

Jeries Kort, Leland Metheny, Pingfu Fu, Parameswaran Hari, Gen Li +8 more

Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.01.053

N/A

0DataRank · unranked

4 citations

Jeries Kort, Leland Metheny, Pingfu Fu, Gen Li, Parameswaran Hari +8 more

Multidisciplinary amyloidosis care in the era of personalized medicine

Frontiers in Neurology(2022)10.3389/fneur.2022.935936

N/A

0DataRank · unranked

14 citations

Rami Kahwash, Samir V. Parikh, Michael Isfort, Miriam Freimer, Ajay Vallakati +6 more

Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients

Frontiers in Oncology(2021)10.3389/fonc.2020.575168

N/A

0DataRank · unranked

17 citations

Ying Huang, Nita Williams, Naresh Bumma, Abdullah Khan, Maria Chaudhry +5 more

The results of multicenter phase II, double-blind placebo-controlled trial of maintenance ixazomib after allogeneic hematopoietic cell transplantation (alloHCT) for high-risk multiple myeloma (MM) from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 1302).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.7003

N/A

0DataRank · unranked

2 citations

Qaiser Bashir, Marcelo C. Pasquini, Michael J. Martens, Juan Wu, Melissa Alsina +11 more